Burry KA

No ORCID on file · 5 papers in corpus
rct 1995
Fertility and sterility ·doi:10.1016/s0015-0282(16)57530-x

OBJECTIVES: To determine the effectiveness of a 3-month course of nafarelin and, furthermore, to determine the long-term efficacy in patients treated for 3 and 6 months with nafarelin for symptoms associated with endometriosis. DESIGN: Dou…

rct 1994
American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(94)90136-8

OBJECTIVE: The study intent was to examine long-term effects on bone mass of 3 or 6 months of nafarelin therapy for endometriosis. STUDY DESIGN: Women with established endometriosis (N = 173) were randomized to receive nafarelin (200 micro…

review 1992
American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(92)91705-f

Quality of life is important when comparing the relative advantages of nafarelin versus danazol for the treatment of endometriosis. Recent studies have investigated the potential differences between the safety profiles of nafarelin and dana…

rct 1991
Fertility and sterility ·doi:10.1016/s0015-0282(16)54590-7

OBJECTIVE: Patients with endometriosis were studied to investigate hormonal suppression by the gonadotropin-releasing hormone against nafarelin acetate compared with danazol. We hypothesized that the pattern, time course, and degree of gona…

rct 1989
American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(89)90870-3

In this double-blind study of changes in plasma lipid and lipoprotein concentrations during 6-month medical treatment of endometriosis, 53 patients were randomly assigned to one of four treatment schedules: danazol, 800 mg/day (n = 10); dan…